Tags : Protein-Based Therapies

Amgen Signs a Research Agreement with the University of Washington’s

Shots: The Institute for Protein Design will utilize its de novo design technique to expand the versatility of protein-based therapies. Amgen has provided funding for three research projects utilizing IPD’s de novo design technique & optimizing Amgen’s repertoire of BiTE Ab The focus of the collaboration is to test new technologies & develop protein-based therapies […]Read More